Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | FemSeven Sequi Phase 2 patches (CST Pharma Ltd) |
| Virtual Medicinal Product | Estradiol 50micrograms/24hours / Levonorgestrel 10micrograms/24hours transdermal patches |
| Name | FemSeven Sequi Phase 2 patches |
| Supplier | CST Pharma Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| Combination product | Component only product |
| EMA additional monitoring | ✗ |
| Parallel import | ✓ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Transdermal |
| Actual Medicinal Product Packs | |
| FemSeven Sequi Phase 2 patches (CST Pharma Ltd) 2 patch | |
| FemSeven Sequi Phase 2 patches (CST Pharma Ltd) 6 patch | |
dm+d data retrieved from TRUD: release NHSBSA_12.2.0_20251215000001, imported on 16th December 2025 at 04:16:28.